Renaissance Technologies »

Ascendis Pharma AS shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $32M 120k 266.72

More positions owned by Renaissance Technologies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Intel Corporation (INTC)
United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl A (GOOGL)
Exelixis (EXEL)
Verisign (VRSN)
Kinross Gold Corp (KGC)
Crowdstrike Hldgs Cl A (CRWD)
Sterling Construction Company (STRL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Argan (AGX)
Netflix (NFLX)

View all positions for Renaissance Technologies

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS